Good podcast? Give it some love!
Signal
SignalEpisodes
Episodes of Signal
Mark All
Search Episodes...
If we told you that a century-old statistical test still rules scientific careers and costs (or makes) companies millions of dollars, wouldn't you wonder why?This Signal podcast was produced by Jocelyn Gonzales. Illustration by Molly Ferguson
How did every parent's worst nightmare — the death of their child — spur the creation of an incentive system to turn making drugs for childhood cancer from a high-risk, low-reward gamble to a bet a company might make?This Signal podcast was p
The Signal podcast is now one year old. And in our first year, we've been able to cover so much truly fascinating science. It's also clear to us how much things have changed — and how much the understanding of science and medicine can evolve in
Today, as Americans head to the polls — and wait for the returns to start coming in — we’re going to take a look back to what history can tell us about the future of our drugs and how we pay for them.And we will also tackle this question: Wil
What if you could stop mosquito-borne diseases before you ever needed to make medicines to treat them? And what if the seeds of destruction for dengue, zika, and malaria could be carried in the genes of mosquitoes themselves?This future is no
We take a deep dive into some of the nefariously creative tricks drug companies use to maintain monopolies and handle competition.This Signal podcast was produced by Jocelyn Gonzales. Illustration by Molly Ferguson for STAT.
In today's show, we take you on a Zika odyssey to meet some odd and unexpected characters, from helpful horses to genetically modified mosquitoes programmed to wipe out their own kind. They are helping to answer this question: Can science, gove
The Chinese hamster has led a secret life in science for decades. By one estimate, 11 biotech drugs that are made using Chinese hamster ovary cells generated an incredible $57 billion in sales in 2013. That's pretty incredible, given the hamste
A deadly new superbug is just starting to surface worldwide. Who is to blame for its rise? Well, us, really. Public health officials are warning we could be headed toward a post-antibiotics world, unless we do something, and fast. So where does
How confident are you that the drugs you take, whether they're over-the-counter or prescription, are totally understood by the companies who make them? Drug makers know what their products do when they enter your body, right? You shouldn't assu
In this episode of Signal, we take on a subject that might make some of our listeners feel uncomfortable — but more importantly, it should make some of our listeners feel heard. This time we talk sexism in biotech.Most of us would like to wor
Cancer plays dirty. Like a gangster. That's how it wins. Over the past few years, scientists have been learning its tricks and tactics. They've learned that it’s a master of adaptation, of escape, of armor, and of stealth -- so maybe it's more
How do our perceptions of risk, and our outsized — or undersized — fears affect our health? In this episode of Signal we explore the killer snail (flu) and the shark (cancer screening) of medicine. (It's a metaphor, people.)The Signal podca
This episode, we bring you a parable of money and medicine at odds. It’s a story of how the vast uncertainties of drug development — and medical mysteries that take months, if not years to unravel — clash with the split-second decisions of inve
Today, one of the big debates in medicine revolves around how much we’re willing to pay for cures.In this latest episode of the Signal podcast, we focus in on hepatitis C, a chronic viral infection of the liver that affects at least 130 milli
Hi, Signal listeners, we have some happy news to share — Meg is getting married! That means we’ll be taking a break for a few weeks, but fear not, Signal will be back in March with fabulous new shows on how our medicines get made. Take a listen
Alzheimer’s disease poses a huge threat to our health and our economy — more than 5 million Americans are estimated to currently have the disease. But it has been as good at evading treatment as just about any disease out there.For decades, s
In the newest episode of Signal, we explore the birth of biotech and the big business behind how our drugs really get made.To do that, we need to take you to San Francisco. About this time every year, biotech nerds everywhere are gearing up t
It’s the holidays! Looking for a gift that really shows you care? How about getting your loved one’s genome sequenced? It took 15 years and $3 billion to sequence the first human genome. Today you can get some genetic information for as littl
Isaac Newton famously said that “If I have seen further, it is by standing on the shoulders of giants.” It’s a crucial point. Scientists discover new things by building on facts established by those who came before.But what if the science tha
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
In this episode we turn the spotlight on a rare but debilitating disease affecting young boys, Duchenne muscular dystrophy. Duchenne boys have a genetic mutation that affects their ability to produce a protein essential for normal muscle func
Who are we? In the debut episode of Signal we take a "gutsy" look into one of the biggest scientific mysteries today - the microbiome.
An introduction to Signal, a podcast from Stat.(Image: Fox Photos/Getty Images)
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us